Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutics|January 28, 2026
Impeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of CancerDragoș Andrei Niculae, Radu Marian Șerban, Dana Niculae, et al.
Pharmaceutics|April 30, 2021
Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon CancerRadu Anton Leonte, Livia Elena Chilug, Radu Șerban, et al.
EJNMMI Physics|May 12, 2025
Optimized production of <sup>89</sup>Zr as a medical radioisotope on a variable energy cyclotron and external beam-lineDiana Cocioabă, Simona Baruta, Liviu Crăciun, et al.
Molecules (Basel, Switzerland)|July 30, 2020
Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate TumoursLivia Elena Chilug, Dana Niculae, Radu Anton Leonte, et al.
Pharmaceutics|June 27, 2025
<sup>89</sup>Zr-Radiolabelling of p-NCS-Bz-DFO-Anti-HER2 Affibody Immunoconjugate: Characterization and Assessment of In Vitro Potential in HER2-Positive Breast Cancer ImagingMaria-Roxana Tudoroiu-Cornoiu, Radu Marian Șerban, Diana Cocioabă, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target ApproachIvanna Hrynchak, Diana Cocioabă, Alexandra I Fonseca, et al.
Molecules (Basel, Switzerland)|March 28, 2024
Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid TargetsDiana Cocioabă, Alexandra I Fonseca, Radu Leonte, et al.
Frontiers in Medicine|July 7, 2023
Modifications in cellular viability, DNA damage and stress responses inflicted in cancer cells by copper-64 ionsRadu M Serban, Dana Niculae, Gina Manda, et al.
Oncology Letters|January 19, 2018
Update on radionuclide therapy in oncologyCornelia Nitipir, Dana Niculae, Cristina Orlov, et al.
Pageof 1